Mergenet Medical, Inc. focuses on developing innovative medical technologies aimed at enhancing respiratory care and improving patient outcomes. Their flagship product line, HiFLO 2®, features non-invasive ventilatory support systems that deliver warm, humidified respiratory gases, including up to 100% oxygen, without the need for a face mask. This technology is designed to provide significant benefits to patients, including improved clinical outcomes and a reduction in healthcare-associated infections. Additionally, the Trach-Assist® system offers a novel approach to airway secretion management, facilitating better care for patients with tracheostomy or endotracheal tubes by integrating with closed suction systems.

Another key technology in Mergenet Medical's portfolio is the CPeX® system, a computer-assisted pulmonary gas exchange tool utilized in clinical settings to diagnose and manage heart and lung diseases. This system plays a crucial role in assessing heart failure and other cardiopulmonary conditions, thereby contributing to enhanced diagnostic accuracy and patient management. Overall, Mergenet Medical is committed to delivering advanced respiratory-related medical products that not only improve the quality of life for patients but also support healthcare professionals in their clinical practices.

United States

MMI ia an incubated entity in Mergenet Solutions, Inc.

Suite 303, Deerfield Beach, Florida, USA, 33442

Mergenet Medical, Inc.

Company Details